ProPublica spent 14 months investigating the FDA’s oversight of foreign drugmakers that send medications to the U.S. These ...

The FDA didn’t routinely test the medications for quality problems or use its vast repository of drug-related complaints to proactively track whether they were harming the people who relied on them.

Sun Pharmaceutical Industries Ltd. closed 15.96% below its 52-week high of 1,960.20 rupees, which the company achieved on ...

We would like to share some important news with you. After years of bringing you the latest insights, analysis and innovation news from the pharma industries, we have made the difficult decision to ...

Backup point guard Sydney Colson, who started in place of injured Caitlin Clark, went down with a left leg injury in the first quarter of Indiana's game Friday against the Sun. Sophie Cunningham ...

With social media influencers making claims that sunscreen is toxic and a base tan can protect you against the sun, a doctor sets the record straight Getty As misinformation runs rampant online ...

Pfizer and Divi's Laboratories outperformance was driven by better than expected revenue growth and margin expansion while Jubilant Pharmova, Dr. Reddy's and Zydus Lifesciences reported lower ...

Shares of Sun Pharma Advanced Research Company Ltd (SPARC) plunged nearly 20% on Wednesday on the NSE, after the company announced disappointing results from Phase 2 trials of its experimental drug, ...

The failure of the Phase 2 studies now casts uncertainty over SPARC’s speciality drug pipeline. Shares of Sun Pharma Advanced Research Company (SPARC), a unit of India’s largest drug maker Sun ...

Sun Pharma Advanced Research Company (SPARC) shares slumped 20 per cent in trade on Wednesday, June 4, 2025, hitting its lower circuit at ₹156.5 per share on BSE. The stock was under pressure after ...